BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Deals

  CryoLife Completes Acquisition of JOTEC

  CryoLife announced today that it has completed its previously announced acquisition of JOTEC.

  December 1, 2017

   · 

  1 min read
• 

  FDA

  FDA Green Lights Eli Lilly’s Taltz to Treat Active Psoriatic Arthritis

  Taltz was first approved by the FDA in March 2016 for the treatment of adult patients with moderate-to-severe plaque psoriasis.

  December 1, 2017

   · 

  8 min read
• Drug Development

  Xynomic Pharma Initiates Ph 1/2 Trial Combining Abexinostat With Ibrutinib in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL) and Mantle Cell Lymphoma (r/r MCL)

  Janssen is providing Ibrutinib only as part of the agreement, with Xynomic providing Abexinostat and support for the trial being conducted at MSK.

  December 1, 2017

   · 

  2 min read